Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase I Study of M6620 (VX-970, Berzosertib) in Combination With Cisplatin and XRT in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC; SDC 10060121)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02567422
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:53.307839+00:00
Published At
2025-06-27T00:00:00+00:00
Record Updated At
2025-12-04
Results Posted At
2025-06-27
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Head and Neck Carcinoma of Unknown Primary", "Head and Neck Squamous Cell Carcinoma", "Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7", "Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7", "Stage III Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7", "Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7", "Stage III Sinonasal Squamous Cell Carcinoma AJCC v6 and v7", "Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7", "Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7", "Stage IV Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7", "Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7", "Stage IV Sinonasal Squamous Cell Carcinoma AJCC v7"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-12-04"
protocolSection.identificationModule.nctId
"NCT02567422"
protocolSection.identificationModule.officialTitle
"A Phase I Study of M6620 (VX-970, Berzosertib) in Combination With Cisplatin and XRT in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC; SDC 10060121)"
protocolSection.statusModule.overallStatus
"ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2025-06-27"

Study condition terms

  • Head and Neck Carcinoma of Unknown Primary (protocolSection.conditionsModule.conditions)
  • Head and Neck Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7 (protocolSection.conditionsModule.conditions)
  • Stage III Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 (protocolSection.conditionsModule.conditions)
  • Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage III Sinonasal Squamous Cell Carcinoma AJCC v6 and v7 (protocolSection.conditionsModule.conditions)
  • Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IV Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 (protocolSection.conditionsModule.conditions)
  • Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IV Sinonasal Squamous Cell Carcinoma AJCC v7 (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.